Advertisement

Topics

Intercytex Company Profile

23:01 EST 9th December 2018 | BioPortfolio

Intercytex is an emerging healthcare company developing and commercialising cell therapy products
for the woundcare and aesthetic medicine markets. Intercytex is using its proprietary expertise in cell therapy to develop products that harness the innate ability of human cells to regenerate and repair the body.
Intercytex has four products in development.
ICX-PRO, designed actively to stimulate repair in chronic wounds - in Phase III trials
ICX-SKN, being developed as a durable and robust skin replacement - due to start Phase I trials during 2006
ICX-RHY, a facial rejuvenation product - in Phase I trials
ICX-TRC, a hair regeneration product - about to commence Phase II trials
Intercytex commenced operations in 2000 and currently employs around 70 staff. In addition to its head office in Cambridge, UK, it has a GMP clinical production facility plus research and development laboratories in Manchester, UK. Additional laboratories are located in Boston, USA.
Intercytex’ shares were admitted for trading on the Alternative Investment Market of the London Stock Exchange on 1 February 2006 under the ticker symbol ICX.L.

Location

St John's Innovation CentreCowley Road
Cambridge
Cambridgeshire
CB4 0WS
United Kingdom

Contact

Phone: 44 (0)1223 421962
Fax: 44 (0)1223 421961
Email: mail@intercytex.com


News Articles [3 Associated News Articles listed on BioPortfolio]

Intercytex and UHSM announce two initial projects for their partnership in Cell Therapy and Regenerative Medicine

Intercytex and UHSM announce two initial projects for their partnership in Cell Therapy and Regenerative Medicine12th November 2013Intercytex Ltd and University Hospital South Manchester NHS Foundatio...

Intercytex reforms as U.S Department of defence funds Vavelta Scar Therapy trials for injured soldiers

Intercytex, the regenerative medicine company, announced on 11 November that it has reformed as a private enterprise and that its lead product, the cell therapy (VAVELTA®) will be evaluated b...

UHSM and Intercytex announce development of a strategic partnership to create a business to accelerate the translation of Regenerative Medicine

Regenerative medicine has the potential to play an increasingly vital role in delivering the next generation of healthcare, offering treatments or possible cures for areas of unmet medical need such a...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Intercytex

Intercytex is an emerging healthcare company developing and commercialising cell therapy products for the woundcare and aesthetic medicine markets. Intercytex is using its proprietary expertise in ...

More Information about "Intercytex" on BioPortfolio

We have published hundreds of Intercytex news stories on BioPortfolio along with dozens of Intercytex Clinical Trials and PubMed Articles about Intercytex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intercytex Companies in our database. You can also find out about relevant Intercytex Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record